Swedish medical technology company Getinge has rolled out Pulsiocare, an advanced hemodynamic monitoring platform that recently received its CE certificate.
The device is designed based on Getinge’s in-house common user interface and offers a modern and intuitive-to-use platform for patient monitoring and hemodynamic assessment.
Pulsiocare builds on the medical technology company’s PulsioFlex platform, a mobile monitor featuring a rechargeable battery and a responsive touchscreen.
The integration of its common user interface enables the device interface to be familiar and easy to navigate, minimising the learning curve for healthcare professionals, said Getinge.
Getinge product manager Laura Kastenmayer said: “This is a complete solution for advanced hemodynamic monitoring in intensive care units and operating rooms, helping physicians understand complex patient conditions.”
Getinge critical care vice president Cecilia Sjöstedt said: “With the CE certificate of Pulsiocare we are bringing a sophisticated level of monitoring to the healthcare industry.
“It is designed to provide healthcare professionals with precise and continuous hemodynamic monitoring, ensuring optimal care of critically ill patients.”
Getinge said that its Pulsiocare monitor provides a full picture of the patient’s hemodynamic status, from the operating room (OR) to the intensive care unit (ICU).
The device features the company’s proven technologies, PiCCO and ProAQT, in a single device, and delivers a clear and customisable data layout for effective decision-making.
Its comprehensive hemodynamic data enables tracking of therapeutic decisions and timely adjustments in the ICU or OR and ensures patient-focused monitoring.
In addition, its advanced technologies, PiCCO and ProAQT measure diverse hemodynamic parameters, displaying critical patient data for faster action, said Getinge.
